Clinical Endpoint Study of Ivermectin 1% Cream

NCT02840461 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

630

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate to Severe Papulopustular Rosacea

Interventions

DRUG: Ivermectin Cream, 1%
DRUG: Placebo/Vehicle cream

Sponsor

Actavis Inc.